Dr Reddy’s Laboratories Ltd has launched Rivastigmine Tartrate capsules in the US market. The capsules are a bioequivalent generic version of Exelon capsules (of Novartis Pharmaceuticals Corporation) in the US market. They are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. The Exelon brand and generic rivastigmine tartrate had U.S. sales of approximately $92.6 million for the most recent twelve months ending June 2011.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: